$0.39 -0.00 (-0.26%) Celsion Corporation - NASDAQ

Jan. 23, 2017 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 0.39
Trade Time: Jan 23 04:00 PM Eastern Daylight Time
Change: +-0.00 (-0.26%)
Prev Close: 0.39
Open: 0.40
Bid: 0.37
Ask: 0.39
  1. No results found.
  1. Celsion to Present Two Posters on its GEN-1 IL-12 Gene-Mediated Immunotherapy at the ASCO-SITC Clinical Immuno-Oncology Symposium

    GlobeNewswire | Jan. 19, 2017 | 08:00AM EST
  2. Mid-Afternoon Market Update: Crude Oil Down 5%; SunCoke Energy Shares Dip Following Q3 Results

    Benzinga | Oct. 12, 2015 | 13:52PM EST
  3. Morning Market Gainers

    Benzinga | Oct. 12, 2015 | 08:43AM EST
  4. Celsion Corporation Enrolls First Patient in the OVATION Study

    Benzinga | Sep. 30, 2015 | 07:04AM EST
  5. Morning Market Gainers

    Benzinga | Jul. 15, 2015 | 08:49AM EST
  6. Benzinga's Top Initiations

    Benzinga | Jul. 15, 2015 | 08:40AM EST
  7. Morning Market Gainers

    Benzinga | Jul. 6, 2015 | 08:51AM EST
  8. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 6, 2015 | 07:17AM EST
  9. Morning Market Losers

    Benzinga | May. 28, 2015 | 08:53AM EST
  10. Celsion Announces Potent, Durable Preclinical Lung Expression Data for Its Novel TheraSilence RNA Program

    Benzinga | May. 21, 2015 | 07:03AM EST
  11. Celsion Corporation Announces ASCO 2015 GEN-1 Immunotherapy Phase 1b Results in Ovarian Cancer Presentation

    Benzinga | May. 13, 2015 | 16:01PM EST
  12. Earnings Scheduled For May 11, 2015

    Benzinga | May. 11, 2015 | 03:04AM EST
  13. Morning Market Gainers

    Benzinga | Apr. 15, 2015 | 08:43AM EST
  14. UPDATE: Celsion Slightly Falls Back Following Treatment News

    Benzinga | Feb. 20, 2015 | 13:04PM EST
  15. Celsion Jumps On Interim Data On Cancer Drug

    Benzinga | Feb. 20, 2015 | 11:45AM EST
Trading Center